Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Pharmaceutical_Distribution_Services
|
| gptkbp:CEO |
Mark_Hooper
|
| gptkbp:employees |
over 1,000
|
| gptkbp:focus |
healthcare_solutions
|
| gptkbp:founded |
1994
|
| gptkbp:headquarters |
gptkb:Melbourne,_Australia
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sigma Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:market |
gptkb:Australia
|
| gptkbp:partnerships |
various healthcare providers
|
| gptkbp:products |
generic medications
|
| gptkbp:regulatoryBody |
gptkb:Therapeutic_Goods_Administration_(TGA)
|
| gptkbp:research |
drug development
|
| gptkbp:revenue |
approximately $1 billion
|
| gptkbp:services |
wholesale distribution
|
| gptkbp:stockExchange |
SIP
|
| gptkbp:subsidiary |
gptkb:Sigma_Healthcare
|
| gptkbp:website |
www.sigmapharmaceuticals.com
|